Name: ARQT Balance Sheet - Arcutis Biotherapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ARQT - Arcutis Biotherapeutics, Inc.

USD | NASDAQ | Healthcare

ARQT Balance Sheet - Arcutis Biotherapeutics Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash And Short Term Investments
Cash And Equivalents	42.9	71.3	88.4	53.6	96.4	65.1	63.3	-	-
Restricted Cash	0.3	0.6	0.9	1.2	1.5	1.5	0.0	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	42.9	71.3	88.4	53.6	96.4	65.1	63.3	-	-
Receivables
Accounts Receivable	146.2	73.1	25.8	8.5	0.0	-	-	-	-
Current Assets
Inventory	22.6	14.5	13.1	7.5	0.0	-	-	-	-
Prepaid Expenses	21.1	19.7	18.7	10.6	14.2
Non-Current Assets
Property, Plant & Equipment Gross	4.3	3.6	3.5	3.0	2.8	2.1	0.3	-	-
Accumulated Depreciation	3.2	2.6	1.9
Current Liabilities
Accounts Payable	12.5	14.2	12.0	8.8	7.4	7.1	1.4	-	-
Short Term Debt	1.0	0.0	-	-	-
Non-Current Liabilities
Long Term Debt	108.0	107.2	201.8	197.8	72.4	0.0	-	-	-
Operating Lease Liabilities Non-Current	5.3	2.6	3.4	4.1
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	1,327.6	1,279.5	1,070.6	930.4
Supplementary Data
Total Debt	109.0	107.2	201.8	197.8	72.4	0.0	-	-	-
Net debt	66.1	35.9	113.4	144.1	(24.1)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q4 FY 17
Cash And Short Term Investments
Cash And Equivalents	34.8	42.9	47.1	72.7	53.1	71.3	134.9	84.3	190.1	88.4	107.5	105.1	81.4	53.6	81.5

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Receivables
Accounts Receivable	144.4	146.2	115.1	106.7	85.4	73.1	60.1	43.4	37.2	25.8	19.4	17.2	12.8	8.5	2.4	-	-	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-

Current Assets
Inventory	37.4	22.6	22.4	16.3	16.6	14.5	14.0	13.9	13.2	13.1	13.9	10.5	8.6	7.5	4.3	-	-	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	32.0	21.1	20.3	18.6	22.9	19.7	18.4	14.2	13.2	18.7	20.2	11.6	13.0	10.6	11.8	12.0	14.1	14.2
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	438.1	411.2	349.2	332.8	323.7	335.8	423.7	434.6	468.1	330.4	281.5	308.9	367.7	437.4	496.7	295.4

Current Liabilities
Accounts Payable	18.3	12.5	5.8	15.1	24.5	14.2	19.3	7.9	13.0	12.0	13.2	17.2	12.5	8.8	8.7	8.4	12.5	7.4	4.9	2.7	3.1	7.1	5.0	8.3	4.8	1.4	-	-	-	-	-
Short Term Debt	8.0	1.0	1.0	1.0	-	0.0	99.5	-	-	0.0	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	-	-	-	-	0.8	0.8	0.8	0.8	0.8	0.7	0.7	0.7	0.7	0.7	0.6	0.6
Accrued Expenses	137.0	116.3	93.0	87.9	65.8	66.8	52.8	42.6	33.6	33.9	28.0	18.8	23.9	28.3	27.8	18.5	20.0	25.5
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	163.2	129.8	99.8	103.9	91.1	81.0	172.4	51.4	47.3	46.7	41.9	36.7	37.0	37.8	37.1

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-
Additional Paid In Capital	1,339.5	1,327.6	1,313.6	1,301.9	1,289.8	1,279.5	1,267.3	1,256.3	1,242.3	1,070.6	962.5	951.6	940.0	930.4	920.1	736.7
Retained Earnings	(1,149.4)	(1,138.1)	(1,155.5)	(1,162.9)	(1,147.0)	(1,121.9)	(1,111.2)	(1,069.6)	(1,017.3)	(981.9)	(915.6)	(870.9)	(799.9)	(719.8)	(647.7)	(540.0)	(472.6)
Accumulated Other Comprehensive Income	(0.5)	(0.0)	(0.1)	(0.0)	(0.1)	(0.0)	0.5	(0.3)	(0.1)	0.0	(0.2)	(0.3)	(0.4)	(1.1)	(1.6)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	189.6	189.5	158.1	139.0	142.7	157.5	156.6	186.4	224.9	88.7	46.7	80.5	139.7	209.6	270.8	195.4	253.8
Total Equity	189.6	189.5	158.1	139.0	142.7	157.5	156.6	186.4	224.9	88.7	46.7	80.5	139.7	209.6	270.8	195.4	253.8	297.7

Supplementary Data
Total Debt	109.4	109.0	108.5	108.0	107.6	107.2	204.6	203.8	202.8	201.8	200.8	199.8	198.8	197.8	196.8	73.1	72.7	72.4	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	74.7	66.1	61.4	35.3	54.5	35.9	69.8	119.5	12.7	113.4	93.3	94.7	117.4	144.1	115.2	11.6	2.9	(24.1)
Working Capital	274.9	281.4	249.5	228.8	232.5	254.8	251.3	383.2	420.8	283.8	239.7	272.2	330.7	399.6	459.6	267.9	326.0	369.4
Book Value	189.6	189.5	158.1	139.0	142.7	157.5	156.6	186.4	224.9	88.7	46.7	80.5	139.7	209.6	270.8	195.4	253.8	297.7
Tangible Book Value	175.4	174.7	142.7	123.0	126.2	148.1	146.8	180.4	218.7	82.2	40.1	73.7	132.7	202.4	263.4	-	-

Non-Current Liabilities
Long Term Debt	101.5	108.0	107.5	107.0	107.6	107.2	105.1	203.8	202.8	201.8	200.8	199.8	198.8	197.8	196.8	73.1	72.7	72.4	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	5.3	5.3	5.3	2.1	2.3	2.6	2.8	3.0	3.2	3.4	3.6	3.8	3.9	4.1	4.3	4.5
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	0.4	0.4	0.4	0.4	0.4	0.6	0.4	0.2	0.3	0.8	-	-	-	-	0.0	0.0
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	270.4	243.5	212.9	213.5	201.4	191.3	280.7	258.3	253.6	252.7	246.2	240.2	239.7	239.7	238.1	105.1